Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.88 USD | +2.07% | +4.35% | +11.39% |
Fiscal Period: January | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.44 | 1.9 | 0.87 | 0.76 | 2.56 | |||||
Return on Total Capital | 4.86 | 2.09 | 0.95 | 0.82 | 2.73 | |||||
Return On Equity % | 5.26 | 0.73 | -2.74 | -1.39 | 2.83 | |||||
Return on Common Equity | 5.26 | 0.73 | -2.74 | -1.39 | 2.83 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 61.26 | 56.62 | 56 | 56.87 | 62.29 | |||||
SG&A Margin | 19.65 | 18.33 | 18.9 | 19.09 | 18.3 | |||||
EBITDA Margin % | 30.92 | 26.71 | 23.5 | 23.08 | 28.13 | |||||
EBITA Margin % | 29.25 | 24.52 | 21.55 | 21.65 | 27.25 | |||||
EBIT Margin % | 20.51 | 10.91 | 5.36 | 4.37 | 12.82 | |||||
Income From Continuing Operations Margin % | 7.46 | 1.2 | -5.85 | -3.03 | 5.57 | |||||
Net Income Margin % | 7.46 | 1.2 | -5.85 | -3.03 | 5.57 | |||||
Net Avail. For Common Margin % | 7.46 | 1.2 | -5.85 | -3.03 | 5.57 | |||||
Normalized Net Income Margin | 10.38 | 3.79 | 0.6 | -0.69 | 5.34 | |||||
Levered Free Cash Flow Margin | 20.76 | 13.22 | 9.21 | 8.08 | 21.2 | |||||
Unlevered Free Cash Flow Margin | 23.67 | 15.5 | 11.65 | 11.22 | 24.38 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.35 | 0.28 | 0.26 | 0.28 | 0.32 | |||||
Fixed Assets Turnover | 8.52 | 6.24 | 7.36 | 11.03 | 16.16 | |||||
Receivables Turnover (Average Receivables) | 11.02 | 10.21 | 9.45 | 9.35 | 9.91 | |||||
Inventory Turnover (Average Inventory) | - | - | - | - | - | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.96 | 2.25 | 2.29 | 2.92 | 4.76 | |||||
Quick Ratio | 1.73 | 1.96 | 2.04 | 2.68 | 4.35 | |||||
Operating Cash Flow to Current Liabilities | 0.69 | 0.89 | 0.92 | 1.15 | 2.07 | |||||
Days Sales Outstanding (Average Receivables) | 33.11 | 35.83 | 38.64 | 39.02 | 36.83 | |||||
Days Outstanding Inventory (Average Inventory) | - | - | - | - | - | |||||
Average Days Payable Outstanding | 6.64 | 3.22 | 15.99 | 20.35 | 12.56 | |||||
Cash Conversion Cycle (Average Days) | - | - | - | - | - | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 126.28 | 77.97 | 54.42 | 52.46 | 45.85 | |||||
Total Debt / Total Capital | 55.81 | 43.81 | 35.24 | 34.41 | 31.44 | |||||
LT Debt/Equity | 121.29 | 72.42 | 53.29 | 51 | 45.39 | |||||
Long-Term Debt / Total Capital | 53.6 | 40.69 | 34.51 | 33.45 | 31.12 | |||||
Total Liabilities / Total Assets | 59.83 | 49.13 | 40.38 | 38.63 | 35.68 | |||||
EBIT / Interest Expense | 4.4 | 2.29 | 1.11 | 0.78 | 2.31 | |||||
EBITDA / Interest Expense | 6.97 | 6.03 | 5.21 | 4.3 | 5.19 | |||||
(EBITDA - Capex) / Interest Expense | 6.68 | 5.65 | 4.97 | 4.23 | 5.16 | |||||
Total Debt / EBITDA | 7.53 | 5.11 | 5.29 | 4.78 | 3.24 | |||||
Net Debt / EBITDA | 6.42 | 3.55 | 4.11 | 3.56 | 1.84 | |||||
Total Debt / (EBITDA - Capex) | 7.86 | 5.45 | 5.55 | 4.86 | 3.26 | |||||
Net Debt / (EBITDA - Capex) | 6.7 | 3.79 | 4.31 | 3.62 | 1.85 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 85.21 | 37.89 | 3.13 | 13.9 | 16 | |||||
Gross Profit, 1 Yr. Growth % | 79.87 | 27.44 | 2.02 | 15.67 | 26.57 | |||||
EBITDA, 1 Yr. Growth % | 71.58 | 19.12 | -9.27 | 11.87 | 41.42 | |||||
EBITA, 1 Yr. Growth % | 68.47 | 15.61 | -9.36 | 14.4 | 46.04 | |||||
EBIT, 1 Yr. Growth % | 40.49 | -26.68 | -49.29 | -7.18 | 240.3 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -46.33 | -77.73 | -601.35 | -40.97 | -313.1 | |||||
Net Income, 1 Yr. Growth % | -46.33 | -77.73 | -601.35 | -40.97 | -313.1 | |||||
Normalized Net Income, 1 Yr. Growth % | 13.17 | -49.67 | -85.94 | -231.14 | -1K | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -50.43 | -79.48 | -547.69 | -41.81 | -306.45 | |||||
Accounts Receivable, 1 Yr. Growth % | 176.08 | 2.69 | 20.15 | 10.76 | 8.32 | |||||
Inventory, 1 Yr. Growth % |